Received: 12 July 2019
Accepted: 9 October 2019
First Online: 6 November 2019
Ethics approval and consent to participate
: Dr. Pinato reports receiving grant funding in support of clinical trials from Merck Sharpe and Dohme and Bristol Myers Squibb and having received speaker/consultancy fees from ViiV Healthcare, Bayer and MiNa therapeutics outside the submitted work. There are no other conflicts of interest to report.